Skip to product information
1 of 1

Cell Tissue

CelltiX Nebulizer

CelltiX Nebulizer

Regular price RM1,700.00 MYR
Regular price Sale price RM1,700.00 MYR
Sale Sold out


It is an extracted communicating vesicles derived from Umbilical Cord-Mesenchymal Stem Cells (MSCs), which deliver to the COVID-19 patient through a nebulizer. Unlike traditional MSCs therapy, it offers an easy-to-use and cost-effective solution for home and hospital-based COVID-19 treatments. This cell-free therapeutic agent reduces the cytokine storm and reverses the inhibition of host anti-viral defences associated with COVID-19, and also enhances mitochondrial function repair lung injuries.


It consists of communicating vesicles, tiny packets filled with cellular proteins and nucleic acid materials (e.g. mRNA & miRNA) released by UC-MSCs. It has powerful regenerative potential, ranging from immune-modulatory properties to anti-inflammatory properties.

Cytokine storm and increased pro-inflammatory signalling biomolecules are primarily responsible for COVID-19 pathogenesis. With it, this COVID-19 pathogenesis is reduced. At the same time, it increases the level of anti-inflammatory signalling mediators that can reduce the severity of lung injury through increased permeability and functional aspects of the alveolar epithelium. As a result, exchanging oxygen-rich air is easily facilitated and helps recover COVID-19 patients.

The ability of our product to transfer mitochondria to alveolar cells further increased their survival rate and thus, facilitated cellular regeneration and was responsible for direct inhibition of viral multiplication.

View full details